Some sarcoma patients improve with T cell immunotherapy

Some sarcoma patients improve with T cell immunotherapy

A clinical trial led by School of Medicine researchers has shown that a T cell immunotherapy — in which the patients’ own T cells are genetically modified to attack and kill cancer cells — is effective in treating some patients with rare cancers of the body’s soft tissues. The study focused on the rare cancers synovial sarcoma and myxoid round cell liposarcoma.
DiPersio honored with E. Donnall Thomas lectureship

DiPersio honored with E. Donnall Thomas lectureship

John F. DiPersio, MD, PhD, the Virginia E. and Sam J. Golman Professor of Medicine at the School of Medicine, delivered the E. Donnall Thomas Lecture in San Antonio at the Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy and the Center for International Blood and Marrow Transplant Research.
Five factors to ensure an infant thrives

Five factors to ensure an infant thrives

In new research published in JAMA Pediatrics, researchers at Washington University make the case that “thrive factors” are a key element of healthy human brain, behavioral and cognitive development. The five thrive factors include: environmental stimulation, nutrition, neighborhood safety, positive caregiving and regular sleep.
AI may predict spread of lung cancer to brain

AI may predict spread of lung cancer to brain

A new study led by Washington University School of Medicine in St. Louis could help physicians strike the right balance when treating lung cancer patients. Scientists used an artificial intelligence (AI) method to study lung biopsy images and predict whether the cancer will spread to the brain.
View More Stories